Happy Thanksgiving! Save 50% on Your MarketBeat All Access Subscription.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Considerations When Rolling Over a 401(k) into a Roth IRA
THE BEST BLACK FRIDAY DEAL YET (Ad)
Airbnb has a plan to fix cleaning fees
Saudi viewers angry over apparent ban on World Cup streaming
THE BEST BLACK FRIDAY DEAL YET (Ad)
Walmart shooting claims teen, young woman, father, mother
Cuba's informal market finds new space on growing internet
See how to make money instead of spending it on Black Friday with this offer (Ad)
Bird flu prompts slaughter of 1.8M chickens in Nebraska
US-England World Cup game seen by 19.98M on US television
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Considerations When Rolling Over a 401(k) into a Roth IRA
THE BEST BLACK FRIDAY DEAL YET (Ad)
Airbnb has a plan to fix cleaning fees
Saudi viewers angry over apparent ban on World Cup streaming
THE BEST BLACK FRIDAY DEAL YET (Ad)
Walmart shooting claims teen, young woman, father, mother
Cuba's informal market finds new space on growing internet
See how to make money instead of spending it on Black Friday with this offer (Ad)
Bird flu prompts slaughter of 1.8M chickens in Nebraska
US-England World Cup game seen by 19.98M on US television
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Considerations When Rolling Over a 401(k) into a Roth IRA
THE BEST BLACK FRIDAY DEAL YET (Ad)
Airbnb has a plan to fix cleaning fees
Saudi viewers angry over apparent ban on World Cup streaming
THE BEST BLACK FRIDAY DEAL YET (Ad)
Walmart shooting claims teen, young woman, father, mother
Cuba's informal market finds new space on growing internet
See how to make money instead of spending it on Black Friday with this offer (Ad)
Bird flu prompts slaughter of 1.8M chickens in Nebraska
US-England World Cup game seen by 19.98M on US television
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Considerations When Rolling Over a 401(k) into a Roth IRA
THE BEST BLACK FRIDAY DEAL YET (Ad)
Airbnb has a plan to fix cleaning fees
Saudi viewers angry over apparent ban on World Cup streaming
THE BEST BLACK FRIDAY DEAL YET (Ad)
Walmart shooting claims teen, young woman, father, mother
Cuba's informal market finds new space on growing internet
See how to make money instead of spending it on Black Friday with this offer (Ad)
Bird flu prompts slaughter of 1.8M chickens in Nebraska
US-England World Cup game seen by 19.98M on US television
OTCMKTS:TKPYY

Takeda Pharmaceutical - TKPYY Stock Forecast, Price & News

$16.59
-0.15 (-0.90%)
(As of 12/21/2018)
Add
Compare
Today's Range
$16.35
$16.92
50-Day Range
$12.42
$14.36
52-Week Range
$15.50
$31.29
Volume
7.86 million shs
Average Volume
979,605 shs
Market Capitalization
$25.92 billion
P/E Ratio
12.11
Dividend Yield
3.44%
Price Target
N/A
TKPYY stock logo

About Takeda Pharmaceutical (OTCMKTS:TKPYY) Stock

Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.

Receive TKPYY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Takeda Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter.

TKPYY Stock News Headlines

Takeda Pharmaceutical Company Limited (TAK)
Takeda: A Lot To Like
Why Translate Bio's Stock Is Trading Lower Today
Takeda Pharma TOURMALINE-MM2 Phase 3 Study Meets Primary Endpoint
Takeda scraps late-stage amyloidosis study
See More Headlines
Receive TKPYY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Takeda Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:TKPYY
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
1781

Profitability

Net Income
$1.68 billion
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$15.99 billion
Cash Flow
$2.21 per share
Book Value
$11.62 per share

Miscellaneous

Outstanding Shares
1,562,360,000
Free Float
N/A
Market Cap
$25.92 billion
Optionable
Not Optionable
Beta
0.42

Social Links


Key Executives

  • Christophe Weber
    President, CEO & Representative Director
  • Constantine Saroukos
    Chief Financial Officer & Director
  • Andrew S. Plump
    Director, President-Research & Development
  • Michael E. Mendelsohn
    Chief Medical & Scientific Officer
  • Norimasa Takeda
    Chief Accounting Officer & Corporate Controller













TKPYY Stock - Frequently Asked Questions

How have TKPYY shares performed in 2022?

Takeda Pharmaceutical's stock was trading at $13.63 at the beginning of the year. Since then, TKPYY shares have increased by 21.7% and is now trading at $16.59.
View the best growth stocks for 2022 here
.

Is Takeda Pharmaceutical a good dividend stock?

Takeda Pharmaceutical (OTCMKTS:TKPYY) pays an annual dividend of $0.58 per share and currently has a dividend yield of 3.44%.

What is Takeda Pharmaceutical's stock symbol?

Takeda Pharmaceutical trades on the OTCMKTS under the ticker symbol "TKPYY."

How do I buy shares of Takeda Pharmaceutical?

Shares of TKPYY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Takeda Pharmaceutical's stock price today?

One share of TKPYY stock can currently be purchased for approximately $16.59.

How much money does Takeda Pharmaceutical make?

Takeda Pharmaceutical (OTCMKTS:TKPYY) has a market capitalization of $25.92 billion and generates $15.99 billion in revenue each year.

Does Takeda Pharmaceutical have any subsidiaries?
The following companies are subsidiares of Takeda Pharmaceutical: ARIAD Pharmaceuticals, Baxalta Manufacturing S.à r.l., IDM Pharma Inc., Intellikine, Inviragen, LigoCyte Pharmaceuticals, Meritage Pharma Inc., Millennium Pharmaceuticals, Millennium Pharmaceuticals Inc., Nihon Pharmaceutical Co. Ltd., Nycomed Pharma, PvP Biologics, Shire, Shire ViroPharma LLC, Takeda (China) Holdings Co. Ltd., Takeda AS, Takeda Austria GmbH, Takeda Bio Development Center, Takeda California Inc., Takeda Consumer Healthcare Company Limited, Takeda Development Center Americas Inc., Takeda Development Center Asia Pte. Ltd., Takeda Development Centre Europe Ltd., Takeda Distribuidora Ltda., Takeda France S.A.S., Takeda GmbH, Takeda Ireland Limited, Takeda Italia S.p.A., Takeda Pharma A/S, Takeda Pharmaceutical (China) Company Limited, Takeda Pharmaceuticals International AG, Takeda Pharmaceuticals Korea Co. Ltd., Takeda Pharmaceuticals Limited Liability Company, Takeda Pharmaceuticals U.S.A. Inc., Takeda UK Limited, Takeda Vaccines Inc., Takeda Vaccines Pte. Ltd., and TiGenix.
Read More
How can I contact Takeda Pharmaceutical?

Takeda Pharmaceutical's mailing address is 1-1 Doshomachi 4-chome Chuo-ku, Osaka M0, 540-8645. The official website for the company is www.takeda.com. The company can be reached via phone at (166) 204-2111.

This page (OTCMKTS:TKPYY) was last updated on 11/28/2022 by MarketBeat.com Staff